Creative Planning Has $1.94 Million Stock Holdings in Cabot Co. (NYSE:CBT)

Creative Planning grew its stake in shares of Cabot Co. (NYSE:CBT - Free Report) by 63.6% in the third quarter, according to its most recent filing with the SEC. The fund owned 17,363 shares of the specialty chemicals company's stock after acquiring an additional 6,749 shares during the period. Creative Planning's holdings in Cabot were worth $1,941,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of CBT. Wealth Enhancement Advisory Services LLC lifted its position in shares of Cabot by 12.5% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 5,924 shares of the specialty chemicals company's stock valued at $546,000 after acquiring an additional 656 shares during the last quarter. State of Michigan Retirement System lifted its position in shares of Cabot by 2.3% during the 1st quarter. State of Michigan Retirement System now owns 13,565 shares of the specialty chemicals company's stock valued at $1,251,000 after acquiring an additional 300 shares during the last quarter. Leeward Investments LLC MA lifted its position in shares of Cabot by 41.1% during the 1st quarter. Leeward Investments LLC MA now owns 163,617 shares of the specialty chemicals company's stock valued at $15,085,000 after acquiring an additional 47,682 shares during the last quarter. SpiderRock Advisors LLC acquired a new stake in shares of Cabot during the 1st quarter valued at $220,000. Finally, Retirement Systems of Alabama raised its stake in Cabot by 0.6% during the 1st quarter. Retirement Systems of Alabama now owns 69,606 shares of the specialty chemicals company's stock valued at $6,418,000 after purchasing an additional 415 shares during the period. Institutional investors and hedge funds own 93.18% of the company's stock.

Insider Activity

In other news, CEO Sean D. Keohane sold 25,617 shares of Cabot stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $101.55, for a total value of $2,601,406.35. Following the transaction, the chief executive officer now owns 331,174 shares of the company's stock, valued at $33,630,719.70. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, CEO Sean D. Keohane sold 25,617 shares of the firm's stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $101.55, for a total value of $2,601,406.35. Following the sale, the chief executive officer now owns 331,174 shares in the company, valued at approximately $33,630,719.70. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Erica Mclaughlin sold 16,390 shares of Cabot stock in a transaction on Tuesday, August 27th. The stock was sold at an average price of $104.24, for a total transaction of $1,708,493.60. Following the sale, the chief financial officer now owns 59,814 shares in the company, valued at $6,235,011.36. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 71,939 shares of company stock valued at $7,308,812 over the last 90 days. 3.07% of the stock is currently owned by company insiders.

Cabot Stock Down 1.3 %

Shares of NYSE CBT traded down $1.39 during mid-day trading on Tuesday, reaching $108.87. The company had a trading volume of 469,273 shares, compared to its average volume of 332,182. The stock has a fifty day moving average of $107.79 and a two-hundred day moving average of $100.52. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.45 and a current ratio of 2.22. The company has a market capitalization of $5.97 billion, a price-to-earnings ratio of 12.95, a PEG ratio of 0.93 and a beta of 1.19. Cabot Co. has a 12-month low of $65.38 and a 12-month high of $117.14.

Cabot (NYSE:CBT - Get Free Report) last issued its quarterly earnings data on Monday, August 5th. The specialty chemicals company reported $1.92 earnings per share for the quarter, beating the consensus estimate of $1.72 by $0.20. The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1 billion. Cabot had a net margin of 12.05% and a return on equity of 26.99%. The company's revenue for the quarter was up 5.0% on a year-over-year basis. During the same quarter last year, the firm earned $1.42 earnings per share. As a group, equities research analysts expect that Cabot Co. will post 7.07 EPS for the current year.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. JPMorgan Chase & Co. upped their price target on Cabot from $95.00 to $105.00 and gave the company a "neutral" rating in a research report on Wednesday, August 7th. UBS Group reduced their price target on shares of Cabot from $103.00 to $98.00 and set a "neutral" rating for the company in a research report on Tuesday, August 6th. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $101.75.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.